In order to test the validity of using spheroplasts to assess peptide translocation, we have measured the cellular localization of four previously characterized peptides (Table 1) . To this end, we exposed E. coli spheroplasts to peptides with an N-terminally conjugated FITC label for imaging; detailed methods for spheroplast preparation and peptide incubation are provided as Supplemental Information. As one set of positive and negative controls, we chose buforin II (BF2), arguably the best studied membrane translocating AMP (15), and BF2 with a P11A mutation that dramatically decreases the peptide's ability to enter cells and lipid vesicles (6, 16).
As an additional non-translocating control we employed magainin 2, a prototypical AMP that acts at the cell membrane (16). As in previous studies, BF2 and magainin peptides included F10W or F5W variations, respectively, which allow for straightforward quantification without significantly altering peptide activity or mechanism. We also considered HipC, a cell-penetrating peptide without antibacterial activity that was previously observed to enter E. coli (5).
All four control peptides showed the same behavior in spheroplasts as when studied with normal E. coli cells (Fig. 2) . Both BF2 and HipC clearly showed entry into the majority of spheroplasts, while P11A BF2 and magainin typically co-localized with membrane dye. For all samples, we found that the use of a membrane dye made it significantly easier to visually distinguish membrane localization from cytosol entry, and no samples showed membrane dye signal contamination on image slices taken from the inside of spheroplasts, regardless of dye intensity.
In addition to providing improved confocal images, working with spheroplasts also allows us to obtain appreciably more individual images than possible when working with normal cells. While the smaller samples of images possible with bacterial cells can allow one to demonstrate qualitative trends, the difficulty of obtaining sufficiently high-quality images makes it infeasible to perform more systematic analyses of entry data. However, with spheroplasts we can consider the percentage of images showing translocation or membrane localization, providing more systematic data (Table 1) . Again, these percentages support the previously observed trends for membrane entry (5, 6, 16), with BF2 and HipC entering significantly more spheroplasts than P11A BF2 and magainin. Interestingly, none of these peptides exclusively exhibit membrane localization or membrane translocation behavior. It is possible that spheroplast behavior differs from bacterial cells or that the observed heterogeneity was related to the exact time of imagingfor example, perhaps all spheroplasts would show entry with BF2 if allowed to incubate for a longer time. However, our observation could also be consistent with the idea that a given AMP may not always follow a single, exclusive mechanism. In fact, there is some evidence for this in previous studies, such as measurements that show the "translocating" BF2 peptide does induce low levels of membrane permeabilization (17), and that the P11A mutation in BF2 reduces but does not eliminate translocation into lipid vesicles (16). It will be interesting for future studies on spheroplasts, bacterial cells, and other model systems to further evaluate this possibility. It is also worth noting that it is impossible to know for certain whether a particular spheroplast is alive, in the process of dying or dead in our images based on the timeframe between peptide incubation and mounting and focusing a slide. While this limitation also occurs for studies with normal bacteria, the optical advantages of spheroplasts may make studies looking at the timeframe of AMP effect on cells more feasible.
In summary, bacterial spheroplasts provide a promising approach for the effective visualization of AMP interactions with bacterial cells. Clearly, there are differences between "normal" Wei et al., 6 bacterial cells and spheroplasts, in particular the lack of the outer cell wall. Researchers will need to take care to ensure that the lack of cell wall does not affect the results observed in spheroplast experiments for peptides. For example, the cell wall may have a "sieving" effect with some larger peptides that would be lost in spheroplasts, requiring additional controls comparing spheroplasts and "normal" cells in other assays (18). However, even with these caveats we believe spheroplasts provide an excellent model system compared to other alternatives to overcome size and shape limitations, such as giant unilamellar vesicles (19-21), as spheroplasts preserve a physiological bacterial membrane composition and are viable if returned to growth conditions (13, 22). Moreover, although spheroplasts have generally been produced from E. coli, protocols can be adjusted to make them from other strains (23). Thus, we believe the use of bacterial spheroplasts can be a useful addition to the toolbox of researchers characterizing AMPs and other membrane active agents, such as cell-penetrating peptides. 
Materials and Methods

Preparation of E. coli Spheroplasts
Spheroplasts were prepared from E. coli strain Top 10 (containing a pET45b plasmid for ampicillin resistance) in steps similar to that described in Martinac et al. Filaments were harvested by centrifugation at 1500 x g for 4 minutes, and the pellet was rinsed without resuspension by gentle addition of 1 mL of 0.8 M sucrose with 1 min incubation at room temperature and then re-suspended in 3 mL of 0.8M sucrose after supernatant has been removed via pipetting. The following reagents were added in order: 150 μL of 1 M Tris Cl (pH 7.8); 120 μL of lysozyme (5mg/ml); 30 μL of Dnase I (5mg/ml); and 120 μL of 0.125 M sodium EDTA (pH 8.0). This mixture was incubated at room temperature for 6 -10 minutes to hydrolyze the peptidoglycan layer, and spheroplast formation was followed under microscope at 1000x. 1 mL of Solution A (20 mM MgCl 2 , 0.7 M sucrose, 10 mM Tris Cl at pH 7.8) was gradually added over a 1 minute period while stirring, and the mixture was incubated for 4 minutes at room temperature. The mixture was layered over two separate 7-mL aliquots of Solution B (10 mM MgCl 2 , 0.8 M sucrose, 10 mM Tris Cl at pH 7.8) previously kept on ice. These mixtures were centrifuged for 2 minutes at 1000 x g to collect spheroplasts into a pellet, and the majority of the supernatant was removed via pipetting. Spheroplast pellets were re-suspended in about 300 μL of remaining liquid.
Confocal Microscopy Imaging of Spheroplasts
Spheroplasts were either prepared immediately before or thawed from frozen stock at -80˚C and Tables 1-4) . Data was generally consistent between different batches, although a few outliers, particularly one batch incubated with buforin II, emphasizes the need for sufficient replication to robustly characterize peptide mechanisms. 
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